• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. 3rd Party
  3. Investing
  1. UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

    UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

  2. UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

    UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

  3. Popular biotech ETF on pace for steepest daily drop in a month

    Popular biotech ETF on pace for steepest daily drop in a month

12345

©2017 Morningstar Advisor. All right reserved.